|
|
||||||||||||||
|
|
|||||||||||||||
Journal of Neurology, Neurosurgery, and Psychiatry, 1990, Vol 53, 854-855
PAPERS |
U Bonuccelli, P Piccini, P Del Dotto, GM Pacifici, GU Corsini and A Muratorio
Institute of Clinical Neurology, University of Pisa, Italy.
Monoamine oxidase B (MAO B) plays a pivotal role in N-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP) induced Parkinsonism. An increased MAO B activity in platelets of patients with idiopathic Parkinson's disease (PD) is reported in this study. The possibility that high MAO B activity may represent a trait of vulnerability for PD by enhancing the neurotoxic effects of environmental compounds is discussed.
| © 1990 by Journal of Neurology, Neurosurgery, and Psychiatry |
This article has been cited by other articles:
![]() |
A. W. Michell, S. J. G. Lewis, T. Foltynie, and R. A. Barker Biomarkers and Parkinson's disease Brain, August 1, 2004; 127(8): 1693 - 1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Park, H. Y. Jung, H. O. Kim, H. Rhim, S. R. Paik, K. C. Chung, J. H. Park, and J. Kim Evidence that alpha -synuclein functions as a negative regulator of Ca++-dependent alpha -granule release from human platelets Blood, September 18, 2002; 100(7): 2506 - 2514. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Migliore, L. Petrozzi, C. Lucetti, G. Gambaccini, S. Bernardini, R. Scarpato, F. Trippi, R. Barale, G. Frenzilli, V. Rodilla, et al. Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients Neurology, June 25, 2002; 58(12): 1809 - 1815. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |